Kedrion Biopharma - Keep Life Flowing

KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.
KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.
KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

News

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

All news.

29-04-2024

Kedrion Announces Rare Disease Medicine RYPLAZIM® Now Available in the United States

Distribution resumes of first and only medicine to treatplasminogen deficiency type 1

12-07-2023

KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB®

Since 2018 Kedrion has had exclusive distribution rights in the US for KEDRAB®

11-09-2023

Kedrion stands with the Immunodeficiency community

Our support for patients’ associations worldwide with the objective of improving the life of individuals affected by PIDs

KEEP LIFE FLOWING